BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 21272039)

  • 1. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff.
    Schmidt-Rose T; Braren S; Fölster H; Hillemann T; Oltrogge B; Philipp P; Weets G; Fey S
    Int J Cosmet Sci; 2011 Jun; 33(3):276-82. PubMed ID: 21272039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efficacy and sensory properties of an anti-dandruff shampoo containing zinc pyrithione and climbazole.
    Turner GA; Matheson JR; Li GZ; Fei XQ; Zhu D; Baines FL
    Int J Cosmet Sci; 2013 Feb; 35(1):78-83. PubMed ID: 22970742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos.
    Draelos ZD; Kenneally DC; Hodges LT; Billhimer W; Copas M; Margraf C
    J Investig Dermatol Symp Proc; 2005 Dec; 10(3):201-4. PubMed ID: 16382664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness and tolerance of climbazole containing dandruff shampoo in patients with seborrheic scalp eczema].
    Wigger-Alberti W; Kluge K; Elsner P
    Praxis (Bern 1994); 2001 Aug; 90(33):1346-9. PubMed ID: 11534318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antidandruff efficacy of a shampoo containing piroctone olamine and salicylic acid in comparison to that of a zinc pyrithione shampoo.
    Lodén M; Wessman C
    Int J Cosmet Sci; 2000 Aug; 22(4):285-9. PubMed ID: 18503415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How I treat … dandruff using a shampoo with a sulfate-free tensio-active].
    Reygagne P; Piérard GE; Loussouarn G; Le Nôtre N; Ziane S
    Rev Med Liege; 2016 Sep; 71(9):365-370. PubMed ID: 28383830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff--a postmarketing study.
    Saple DG; Ravichandran G; Desai A
    J Indian Med Assoc; 2000 Dec; 98(12):810-1. PubMed ID: 11394481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea.
    Lee JH; Lee HS; Eun HC; Cho KH
    J Dermatolog Treat; 2003 Dec; 14(4):212-5. PubMed ID: 14660265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment.
    Lorette G; Ermosilla V
    Eur J Dermatol; 2006; 16(5):558-64. PubMed ID: 17101479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of anti-dandruff shampoos: a randomized clinical trial comparing products based on potentiated zinc pyrithione and zinc pyrithione/climbazole.
    Schwartz JR; Bacon RA; Shah R; Mizoguchi H; Tosti A
    Int J Cosmet Sci; 2013 Aug; 35(4):381-7. PubMed ID: 23614401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced delivery of an anti-dandruff active in a shampoo vehicle.
    Georgalas A
    J Cosmet Sci; 2004; 55 Suppl():S207-14. PubMed ID: 15645098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
    Ratnavel RC; Squire RA; Boorman GC
    J Dermatolog Treat; 2007; 18(2):88-96. PubMed ID: 17520465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dandruff/seborrhoeic dermatitis is characterized by an inflammatory genomic signature and possible immune dysfunction: transcriptional analysis of the condition and treatment effects of zinc pyrithione.
    Mills KJ; Hu P; Henry J; Tamura M; Tiesman JP; Xu J
    Br J Dermatol; 2012 Jun; 166 Suppl 2():33-40. PubMed ID: 22670617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of novel cosmetic shampoo formulations against Malassezia species: Preliminary results of anti-dandruff shampoo formulations.
    Ergin Ç; Kurt Ö; Türkoğlu M; Sevinç H; Akbaba G
    J Cosmet Dermatol; 2024 Mar; ():. PubMed ID: 38544350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive and simultaneous quantification of zinc pyrithione and climbazole deposition from anti-dandruff shampoos onto human scalp.
    Chen G; Miao M; Hoptroff M; Fei X; Collins LZ; Jones A; Janssen HG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1003():22-6. PubMed ID: 26397749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis.
    Piérard-Franchimont C; Goffin V; Decroix J; Piérard GE
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):434-41. PubMed ID: 12476017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced piroctone olamine retention from shampoo for superior anti-dandruff efficacy.
    Johnson ES; Chang DW; Schwartz JR; Blume-Peytavi U; Henry JP; Caterino TL; Talley AL
    Int J Cosmet Sci; 2023 Apr; 45(2):236-245. PubMed ID: 36573829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.
    Roques C; Brousse S; Panizzutti C
    Mycopathologia; 2006 Dec; 162(6):395-400. PubMed ID: 17146583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro efficacy of antifungal agents alone and in shampoo formulation against dandruff-associated Malassezia spp. and Staphylococcus spp.
    Leong C; Schmid B; Buttafuoco A; Glatz M; Bosshard PP
    Int J Cosmet Sci; 2019 Jun; 41(3):221-227. PubMed ID: 30851208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.